{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,18]],"date-time":"2026-09-18T01:05:33Z","timestamp":1789693533060,"version":"4.0.1"},"reference-count":50,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","gynecologiconcology-online.net","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Gynecologic Oncology"],"published-print":{"date-parts":[[2026,9]]},"DOI":"10.1016\/j.ygyno.2026.08.013","type":"journal-article","created":{"date-parts":[[2026,8,28]],"date-time":"2026-08-28T16:24:29Z","timestamp":1787934269000},"page":"188-198","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["The science and conduct of surgical trials in gynecologic oncology: A practical framework"],"prefix":"10.1016","volume":"212","author":[{"given":"Nuria","family":"Agust\u00ed","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alexandra","family":"Bercow","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anne","family":"Knisely","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andreas","family":"Obermair","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anna","family":"Fagotti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marie","family":"Plante","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Philipp","family":"Harter","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pedro T.","family":"Ram\u00edrez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J. Alejandro","family":"Rauh-Hain","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ygyno.2026.08.013_bb0005","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejca.2016.01.017","article-title":"Phase III randomised clinical trial comparing primary surgery versus neoadjuvant chemotherapy in advanced epithelial ovarian cancer with high tumour load (SCORPION trial): final analysis of peri-operative outcome","volume":"59","author":"Fagotti","year":"2016","journal-title":"Eur. J. Cancer"},{"key":"10.1016\/j.ygyno.2026.08.013_bb0010","doi-asserted-by":"crossref","DOI":"10.1136\/ijgc-2020-001640","article-title":"Randomized trial of primary debulking surgery versus neoadjuvant chemotherapy for advanced epithelial ovarian cancer (SCORPION-NCT01461850)","volume":"30","author":"Fagotti","year":"2020","journal-title":"Int. J. Gynecol. Cancer"},{"key":"10.1016\/j.ygyno.2026.08.013_bb0015","doi-asserted-by":"crossref","DOI":"10.1056\/NEJMoa1808424","article-title":"A randomized trial of lymphadenectomy in patients with advanced ovarian neoplasms","volume":"380","author":"Harter","year":"2019","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.ygyno.2026.08.013_bb0020","doi-asserted-by":"crossref","DOI":"10.1200\/JCO.2011.41.2528","article-title":"Lymphatic mapping and sentinel lymph node biopsy in women with squamous cell carcinoma of the vulva: a gynecologic oncology group study","volume":"30","author":"Levenback","year":"2012","journal-title":"J. Clin. Oncol."},{"key":"10.1016\/j.ygyno.2026.08.013_bb0025","doi-asserted-by":"crossref","DOI":"10.1001\/jama.2017.2068","article-title":"Effect of total laparoscopic hysterectomy vs total abdominal hysterectomy on disease-free survival among women with stage i endometrial cancer: a randomized clinical trial","volume":"317","author":"Janda","year":"2017","journal-title":"JAMA"},{"key":"10.1016\/j.ygyno.2026.08.013_bb0030","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1097\/SLA.0000000000002794","article-title":"No surgical innovation without evaluation","volume":"269","author":"Hirst","year":"2019","journal-title":"Ann. Surg."},{"key":"10.1016\/j.ygyno.2026.08.013_bb0035","doi-asserted-by":"crossref","DOI":"10.1016\/S1470-2045(18)30566-7","article-title":"Neoadjuvant chemotherapy versus debulking surgery in advanced tubo-ovarian cancers: pooled analysis of individual patient data from the EORTC 55971 and CHORUS trials","volume":"19","author":"Vergote","year":"2018","journal-title":"Lancet Oncol."},{"key":"10.1016\/j.ygyno.2026.08.013_bb0040","doi-asserted-by":"crossref","first-page":"2398","DOI":"10.1200\/JCO.19.00022","article-title":"Role of neoadjuvant chemotherapy in advanced epithelial ovarian cancer","volume":"37","author":"du Bois","year":"2019","journal-title":"J. Clin. Oncol."},{"key":"10.1016\/j.ygyno.2026.08.013_bb0045","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1016\/S0140-6736(14)62223-6","article-title":"Primary chemotherapy versus primary surgery for newly diagnosed advanced ovarian cancer (CHORUS): an open-label, randomised, controlled, non-inferiority trial","volume":"386","author":"Kehoe","year":"2015","journal-title":"Lancet"},{"key":"10.1016\/j.ygyno.2026.08.013_bb0050","doi-asserted-by":"crossref","first-page":"943","DOI":"10.1056\/NEJMoa0908806","article-title":"Neoadjuvant chemotherapy or primary surgery in stage IIIC or IV ovarian cancer","volume":"363","author":"Vergote","year":"2010","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.ygyno.2026.08.013_bb0055","doi-asserted-by":"crossref","DOI":"10.1016\/j.ajog.2008.06.052","article-title":"Prospective validation of a laparoscopic predictive model for optimal cytoreduction in advanced ovarian carcinoma","volume":"199","author":"Fagotti","year":"2008","journal-title":"Am. J. Obstet. Gynecol."},{"key":"10.1016\/j.ygyno.2026.08.013_bb0060","doi-asserted-by":"crossref","DOI":"10.1136\/ijgc-2019-000682","article-title":"TRUST: Trial of Radical Upfront Surgical Therapy in advanced ovarian cancer (ENGOT ov33\/AGO-OVAR OP7)","volume":"29","author":"Reuss","year":"2019","journal-title":"Int. J. Gynecol. Cancer"},{"key":"10.1016\/j.ygyno.2026.08.013_bb0065","doi-asserted-by":"crossref","DOI":"10.1056\/NEJMoa2308900","article-title":"Simple versus radical hysterectomy in women with low-risk cervical cancer","volume":"390","author":"Plante","year":"2024","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.ygyno.2026.08.013_bb0070","doi-asserted-by":"crossref","DOI":"10.1200\/JCO.2011.38.8645","article-title":"Recurrence and survival after random assignment to laparoscopy versus laparotomy for comprehensive surgical staging of uterine cancer: Gynecologic Oncology Group LAP2 study","volume":"30","author":"Walker","year":"2012","journal-title":"J. Clin. Oncol."},{"key":"10.1016\/j.ygyno.2026.08.013_bb0075","doi-asserted-by":"crossref","DOI":"10.1056\/NEJMoa1708618","article-title":"Hyperthermic intraperitoneal chemotherapy in ovarian cancer","volume":"378","author":"van Driel","year":"2018","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.ygyno.2026.08.013_bb0080","doi-asserted-by":"crossref","DOI":"10.1001\/jamanetworkopen.2024.46325","article-title":"Laparoscopic cytoreduction after neoadjuvant chemotherapy in high-grade epithelial ovarian cancer: a LANCE randomized clinical trial","volume":"7","author":"Rauh-Hain","year":"2024","journal-title":"JAMA Netw. Open"},{"key":"10.1016\/j.ygyno.2026.08.013_bb0085","doi-asserted-by":"crossref","first-page":"1463","DOI":"10.1056\/NEJMoa2506267","article-title":"Sentinel-lymph-node biopsy alone or with lymphadenectomy in cervical cancer","volume":"393","author":"Tu","year":"2025","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.ygyno.2026.08.013_bb0090","doi-asserted-by":"crossref","DOI":"10.1001\/jamanetworkopen.2021.14494","article-title":"Characteristics of randomized clinical trials in surgery from 2008 to 2020: a systematic review","volume":"4","author":"Robinson","year":"2021","journal-title":"JAMA Netw. Open"},{"key":"10.1016\/j.ygyno.2026.08.013_bb0095","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1001\/jamasurg.2022.4898","article-title":"Practical guide to quality control in surgical trials","volume":"158","author":"Kim","year":"2023","journal-title":"JAMA Surg."},{"key":"10.1016\/j.ygyno.2026.08.013_bb0100","doi-asserted-by":"crossref","DOI":"10.1136\/ijgc-2020-001584","article-title":"Laparoscopic cytoreduction after neoadjuvant ChEmotherapy (LANCE)","volume":"30","author":"Nitecki","year":"2020","journal-title":"Int. J. Gynecol. Cancer"},{"key":"10.1016\/j.ygyno.2026.08.013_bb0105","doi-asserted-by":"crossref","DOI":"10.3802\/jgo.2024.35.e48","article-title":"Challenges and perspectives on less invasive surgery for early-stage cervical cancer: a critical analysis of the SHAPE trial and its implications","volume":"35","author":"Takekuma","year":"2024","journal-title":"J. Gynecol. Oncol."},{"key":"10.1016\/j.ygyno.2026.08.013_bb0110","doi-asserted-by":"crossref","DOI":"10.1136\/ijgc-2021-003029","article-title":"A phase III randomized clinical trial comparing sentinel node biopsy with no retroperitoneal node dissection in apparent early-stage endometrial cancer \u2013 ENDO-3: ANZGOG trial 1911\/2020","volume":"31","author":"Obermair","year":"2021","journal-title":"Int. J. Gynecol. Cancer"},{"key":"10.1016\/j.ygyno.2026.08.013_bb0115","doi-asserted-by":"crossref","first-page":"295","DOI":"10.7326\/0003-4819-148-4-200802190-00008","article-title":"Extending the CONSORT statement to randomized trials of nonpharmacologic treatment: explanation and elaboration","volume":"148","author":"Boutron","year":"2008","journal-title":"Ann. Intern. Med."},{"key":"10.1016\/j.ygyno.2026.08.013_bb0120","doi-asserted-by":"crossref","first-page":"40","DOI":"10.7326\/M17-0046","article-title":"CONSORT statement for randomized trials of nonpharmacologic treatments: a 2017 update and a CONSORT extension for nonpharmacologic trial abstracts","volume":"167","author":"Boutron","year":"2017","journal-title":"Ann. Intern. Med."},{"key":"10.1016\/j.ygyno.2026.08.013_bb0125","doi-asserted-by":"crossref","DOI":"10.1093\/bjsopen\/zrae124","article-title":"Automated analysis of operative video in surgical training: scoping review","volume":"8","author":"Dick","year":"2024","journal-title":"BJS Open"},{"key":"10.1016\/j.ygyno.2026.08.013_bb0130","doi-asserted-by":"crossref","DOI":"10.1093\/bjsopen\/zraf082","article-title":"Quality assurance of surgical interventions for pancreatic cancer: systematic review of multicentre randomized clinical trials","volume":"9","author":"Helliwell","year":"2025","journal-title":"BJS Open"},{"key":"10.1016\/j.ygyno.2026.08.013_bb0135","doi-asserted-by":"crossref","first-page":"1377","DOI":"10.1002\/bjs.10254","article-title":"Standardizing and monitoring the delivery of surgical interventions in randomized clinical trials","volume":"103","author":"Blencowe","year":"2016","journal-title":"Br. J. Surg."},{"key":"10.1016\/j.ygyno.2026.08.013_bb0140","doi-asserted-by":"crossref","DOI":"10.1016\/j.ygyno.2021.10.008","article-title":"Secondary cytoreductive surgery for recurrent ovarian cancer: an SGO clinical practice statement","volume":"163","author":"Harrison","year":"2021","journal-title":"Gynecol. Oncol."},{"key":"10.1016\/j.ygyno.2026.08.013_bb0145","doi-asserted-by":"crossref","first-page":"1929","DOI":"10.1056\/NEJMoa1902626","article-title":"Secondary surgical cytoreduction for recurrent ovarian cancer","volume":"381","author":"Coleman","year":"2019","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.ygyno.2026.08.013_bb0150","doi-asserted-by":"crossref","first-page":"2123","DOI":"10.1056\/NEJMoa2103294","article-title":"Randomized trial of cytoreductive surgery for relapsed ovarian cancer","volume":"385","author":"Harter","year":"2021","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.ygyno.2026.08.013_bb0155","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1097\/01.sla.0000133083.54934.ae","article-title":"Classification of surgical complications: a new proposal with evaluation in a cohort of 6336 patients and results of a survey","volume":"240","author":"Dindo","year":"2004","journal-title":"Ann. Surg."},{"key":"10.1016\/j.ygyno.2026.08.013_bb0160","unstructured":"Common Terminology Criteria for Adverse Events (CTCAE) Version 5.0. 2017."},{"key":"10.1016\/j.ygyno.2026.08.013_bb0165","doi-asserted-by":"crossref","DOI":"10.1186\/s12998-026-00658-8","article-title":"Adverse event reporting in randomized trials of spinal manipulative therapy: a scoping review of practices and characteristics","author":"Funabashi","year":"2026","journal-title":"Chiropr Man Therap"},{"key":"10.1016\/j.ygyno.2026.08.013_bb0170","doi-asserted-by":"crossref","first-page":"1570","DOI":"10.1016\/j.surg.2021.12.011","article-title":"Classification of intraoperative adverse events in visceral surgery","volume":"171","author":"Gawria","year":"2022","journal-title":"Surgery"},{"key":"10.1016\/j.ygyno.2026.08.013_bb0175","article-title":"Prospective validation of classification of intraoperative adverse events (ClassIntra): international, multicentre cohort study","volume":"370","author":"Dell-Kuster","year":"2020","journal-title":"BMJ"},{"key":"10.1016\/j.ygyno.2026.08.013_bb0180","doi-asserted-by":"crossref","first-page":"1120","DOI":"10.1016\/j.jamcollsurg.2013.12.060","article-title":"Derivation and validation of a novel severity classification for intraoperative adverse events","volume":"218","author":"Kaafarani","year":"2014","journal-title":"J. Am. Coll. Surg."},{"key":"10.1016\/j.ygyno.2026.08.013_bb0185","doi-asserted-by":"crossref","first-page":"2372","DOI":"10.1245\/s10434-008-0042-8","article-title":"The role of health-related quality of life outcomes in clinical decision making in surgery for esophageal cancer: a systematic review","volume":"15","author":"Parameswaran","year":"2008","journal-title":"Ann. Surg. Oncol."},{"key":"10.1016\/j.ygyno.2026.08.013_bb0190","doi-asserted-by":"crossref","first-page":"1889","DOI":"10.1007\/s11136-012-0344-y","article-title":"ISOQOL recommends minimum standards for patient-reported outcome measures used in patient-centered outcomes and comparative effectiveness research","volume":"22","author":"Reeve","year":"2013","journal-title":"Qual. Life Res."},{"key":"10.1016\/j.ygyno.2026.08.013_bb0195","doi-asserted-by":"crossref","first-page":"814","DOI":"10.1001\/jama.2013.879","article-title":"Reporting of patient-reported outcomes in randomized trials: the CONSORT PRO extension","volume":"309","author":"Calvert","year":"2013","journal-title":"JAMA"},{"key":"10.1016\/j.ygyno.2026.08.013_bb0200","doi-asserted-by":"crossref","first-page":"967","DOI":"10.1016\/j.jval.2011.06.014","volume":"14","author":"Patrick","year":"2011","journal-title":"Value Health"},{"key":"10.1016\/j.ygyno.2026.08.013_bb0205","doi-asserted-by":"crossref","first-page":"814","DOI":"10.1001\/jama.2013.879","article-title":"Reporting of patient-reported outcomes in randomized trials","volume":"309","author":"Calvert","year":"2013","journal-title":"JAMA"},{"key":"10.1016\/j.ygyno.2026.08.013_bb0210","doi-asserted-by":"crossref","DOI":"10.1200\/JCO.2025.43.17_suppl.LBA5500","article-title":"TRUST: trial of radical upfront surgical therapy in advanced ovarian cancer (ENGOT ov33\/AGO-OVAR OP7)","volume":"43","author":"Mahner","year":"2025","journal-title":"J. Clin. Oncol."},{"key":"10.1016\/j.ygyno.2026.08.013_bb0220","doi-asserted-by":"crossref","first-page":"619","DOI":"10.1136\/ijgc-2022-004122","volume":"33","author":"Gien","year":"2023","journal-title":"Int. J. Gynecol. Cancer"},{"key":"10.1016\/j.ygyno.2026.08.013_bb0225","doi-asserted-by":"crossref","first-page":"439","DOI":"10.1016\/S1470-2045(21)00006-1","article-title":"Secondary cytoreduction followed by chemotherapy versus chemotherapy alone in platinum-sensitive relapsed ovarian cancer (SOC-1): a multicentre, open-label, randomised, phase 3 trial","volume":"22","author":"Shi","year":"2021","journal-title":"Lancet Oncol."},{"key":"10.1016\/j.ygyno.2026.08.013_bb0230","doi-asserted-by":"crossref","first-page":"1551","DOI":"10.1016\/S1470-2045(24)00531-X","article-title":"Hyperthermic intraperitoneal chemotherapy for recurrent ovarian cancer (CHIPOR): a randomised, open-label, phase 3 trial","volume":"25","author":"Classe","year":"2024","journal-title":"Lancet Oncol."},{"key":"10.1016\/j.ygyno.2026.08.013_bb0235","doi-asserted-by":"crossref","first-page":"384","DOI":"10.1016\/S1470-2045(17)30068-2","article-title":"A comparison of sentinel lymph node biopsy to lymphadenectomy for endometrial cancer staging (FIRES trial): a multicentre, prospective, cohort study","volume":"18","author":"Rossi","year":"2017","journal-title":"Lancet Oncol."},{"key":"10.1016\/j.ygyno.2026.08.013_bb0240","doi-asserted-by":"crossref","DOI":"10.1056\/NEJMoa1806395","article-title":"Minimally invasive versus abdominal radical hysterectomy for cervical cancer","volume":"379","author":"Ramirez","year":"2018","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.ygyno.2026.08.013_bb0245","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1016\/j.ejca.2021.02.009","article-title":"Sentinel lymph node biopsy and morbidity outcomes in early cervical cancer: results of a multicentre randomised trial (SENTICOL-2)","volume":"148","author":"Mathevet","year":"2021","journal-title":"Eur. J. Cancer"},{"key":"10.1016\/j.ygyno.2026.08.013_bb0250","doi-asserted-by":"crossref","first-page":"884","DOI":"10.1200\/JCO.2007.14.0566","article-title":"Sentinel node dissection is safe in the treatment of early-stage vulvar cancer","volume":"26","author":"Van der Zee","year":"2008","journal-title":"J. Clin. Oncol."},{"key":"10.1016\/j.ygyno.2026.08.013_bb0255","doi-asserted-by":"crossref","first-page":"3623","DOI":"10.1200\/JCO.21.00006","article-title":"Radiotherapy versus inguinofemoral lymphadenectomy as treatment for vulvar cancer patients with micrometastases in the sentinel node: results of GROINSS-V II","volume":"39","author":"Oonk","year":"2021","journal-title":"J. Clin. Oncol."}],"container-title":["Gynecologic Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0090825826021050?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0090825826021050?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,9,18]],"date-time":"2026-09-18T00:42:02Z","timestamp":1789692122000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0090825826021050"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,9]]},"references-count":50,"alternative-id":["S0090825826021050"],"URL":"https:\/\/doi.org\/10.1016\/j.ygyno.2026.08.013","relation":{},"ISSN":["0090-8258"],"issn-type":[{"value":"0090-8258","type":"print"}],"subject":[],"published":{"date-parts":[[2026,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"The science and conduct of surgical trials in gynecologic oncology: A practical framework","name":"articletitle","label":"Article Title"},{"value":"Gynecologic Oncology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ygyno.2026.08.013","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}]}}